All of the following statements about Myasthenia Gravis are true, except:
Anti-AChR antibodies are the most common antibodies in generalized myasthenia gravis The pathogenic Anti-AChR antibodies are IgG antibodies Anti-MuSK antibodies are directed against muscarinic ACh receptors The major defect is a decrease in the number of available ACh receptors